Articles with public access mandates - Pieter Van der VekenLearn more
Not available anywhere: 19
Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy?
M Berg, P Van der Veken, A Goeminne, A Haemers, K Augustyns
Current medicinal chemistry 17 (23), 2456-2481, 2010
Mandates: Research Foundation (Flanders)
Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives
I El Sayed, P Van der Veken, K Steert, L Dhooghe, S Hostyn, ...
Journal of medicinal chemistry 52 (9), 2979-2988, 2009
Mandates: Research Foundation (Flanders)
Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas
K Dillen, C Bridts, P Van der Veken, P Cos, J Vandervoort, K Augustyns, ...
International journal of pharmaceutics 349 (1-2), 234-240, 2008
Mandates: Research Foundation (Flanders)
Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates
P Van der Veken, A Soroka, I Brandt, YS Chen, MB Maes, AM Lambeir, ...
Journal of medicinal chemistry 50 (23), 5568-5570, 2007
Mandates: Research Foundation (Flanders)
Mass spectrometric characterization of organosulfates related to secondary organic aerosol from isoprene
M Safi Shalamzari, O Ryabtsova, A Kahnt, R Vermeylen, MF Hérent, ...
Rapid Communications in Mass Spectrometry 27 (7), 784-794, 2013
Mandates: Research Foundation (Flanders)
Tozasertib analogues as inhibitors of necroptotic cell death
S Hofmans, L Devisscher, S Martens, D Van Rompaey, K Goossens, ...
Journal of Medicinal Chemistry 61 (5), 1895-1920, 2018
Mandates: Research Foundation (Flanders), Belgian Science Policy Office
Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis
I Coornaert, S Hofmans, L Devisscher, K Augustyns, P Van Der Veken, ...
Expert Opinion on Drug Discovery 13 (6), 477-488, 2018
Mandates: Research Foundation (Flanders)
P2-Substituted N-Acylprolylpyrrolidine Inhibitors of Prolyl Oligopeptidase: Biochemical Evaluation, Binding Mode Determination, and Assessment in a Cellular …
P Van der Veken, V Fülöp, D Rea, M Gerard, R Van Elzen, J Joossens, ...
Journal of medicinal chemistry 55 (22), 9856-9867, 2012
Mandates: Research Foundation (Flanders)
Synthesis and evaluation of a Zr-89-labeled monoclonal antibody for immuno-PET imaging of amyloid-β deposition in the brain
J Fissers, AM Waldron, T De Vijlder, B Van Broeck, DJ Pemberton, ...
Molecular imaging and biology 18, 598-605, 2016
Mandates: Research Foundation (Flanders)
Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)
M Venkatraj, J Messagie, J Joossens, AM Lambeir, A Haemers, ...
Bioorganic & medicinal chemistry 20 (4), 1557-1568, 2012
Mandates: Research Foundation (Flanders)
Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor
F Giannese, M Berg, P Van der Veken, V Castagna, P Tornaghi, ...
Acta Crystallographica Section D: Biological Crystallography 69 (8), 1553-1566, 2013
Mandates: Government of Italy
Vildagliptin‐Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9‐Specific Lead
S Benramdane, J De Loose, O Beyens, Y Van Rymenant, G Vliegen, ...
ChemMedChem 17 (15), e202200097, 2022
Mandates: Research Foundation (Flanders)
The first potent diphenyl phosphonate KLK4 inhibitors with unexpected binding kinetics
J Soom, GC Crucitti, P der Veken, RD Santo
MedChemComm 6 (11), 1954-1958, 2015
Mandates: Research Foundation (Flanders), German Research Foundation
Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis
D Leenaerts, J Aernouts, P Van Der Veken, Y Sim, AM Lambeir, ...
Thrombosis and haemostasis 117 (08), 1498-1508, 2017
Mandates: Research Foundation (Flanders)
Repositioning the Substrate Activity Screening (SAS) Approach as a Fragment‐Based Method for Identification of Weak Binders
R Gladysz, M Cleenewerck, J Joossens, AM Lambeir, K Augustyns, ...
ChemBioChem 15 (15), 2238-2247, 2014
Mandates: Research Foundation (Flanders)
Highly selective inhibitors of dipeptidyl peptidase 9 (DPP9) derived from the clinically used DPP4-inhibitor vildagliptin
S Benramdane, J De Loose, N Filippi, M Espadinha, O Beyens, ...
Journal of Medicinal Chemistry 66 (18), 12717-12738, 2023
Mandates: Research Foundation (Flanders), European Commission
Chlorination of Arylaldehyde-Derived Arylsulfonylhydrazones with N-Chlorosuccinimide Leading to 1, 2, 4, 5-Tetrazine Derivatives
YZ Ji, HJ Li, Y Liu, YC Wu
Synthesis 52 (01), 69-74, 2020
Mandates: National Natural Science Foundation of China
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases
C Scarpellini, G Klejborowska, C Lanthier, A Toye, K Musiałek, E Van San, ...
Journal of Medicinal Chemistry, 2025
Mandates: European Commission
3rd International Conference on Dipeptidyl Peptidase and Related Proteins
I De Meester, S Scharpé, A Haemers, MM Lambeir, L Polgar, A Sedo, ...
Clin Chem Lab Med 46 (4), A1-A43, 2008
Mandates: German Research Foundation
Available somewhere: 96
3‐methyl‐1, 2, 3‐butanetricarboxylic acid: An atmospheric tracer for terpene secondary organic aerosol
R Szmigielski, JD Surratt, Y Gómez‐González, P Van der Veken, ...
Geophysical Research Letters 34 (24), 2007
Mandates: Research Foundation (Flanders)
Publication and funding information is determined automatically by a computer program